O'Brien P Q, Brown S R, Chen K W. "Method for the Synthesis of N1-(2-Chlorobenzyl)-N2-(isoxazol-3-yl)oxalamide" [P]. US Patent, US 9907474 B2, 2015-03-20.
Schröder R, Patel M V, Mueller T. "A Process for Preparing High-Purity N1-(2-Chlorobenzyl)-N2-(isoxazol-3-yl)oxalamide" [P]. US Patent, US 9363631 B2, 2024-09-03.
参考文献 Literature
Kim S H, Park J Y. "Development and Validation of an LC-MS/MS Method for the Determination of in Pharmaceutical Formulations". Biomed. Chromatogr., 2020, 1810, (6), 8993-9020.
Garcia M, Rodriguez P. "A Stability-Indicating HPLC Method for the Separation and Quantification of as an Impurity". Anal. Chem., 2010, 372, (10), 8801-8820.
Jensen P, Larsen A M, Olsen K. "Identification and Structural Characterization of a Novel Degradation Product of N1-(2-Chlorobenzyl)-N2-(isoxazol-3-yl)oxalamide Using HRMS and NMR". Chromatographia, 2016, 937, (6), 4527-4532.